Atlas Trials

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

Clinical trial NCT07024277 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07024277
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Prostate Cancer
Start date
2025-08-01
Primary completion
2027-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.